Does INFLIXIMAB-DYYB Cause Hepatic enzyme increased? 167 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 167 reports of Hepatic enzyme increased have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 0.7% of all adverse event reports for INFLIXIMAB-DYYB.
167
Reports of Hepatic enzyme increased with INFLIXIMAB-DYYB
0.7%
of all INFLIXIMAB-DYYB reports
4
Deaths
54
Hospitalizations
How Dangerous Is Hepatic enzyme increased From INFLIXIMAB-DYYB?
Of the 167 reports, 4 (2.4%) resulted in death, 54 (32.3%) required hospitalization, and 7 (4.2%) were considered life-threatening.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 167 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB-DYYB Cause?
Off label use (14,256)
Condition aggravated (10,275)
Intentional product use issue (7,549)
Inappropriate schedule of product administration (5,977)
Arthralgia (4,615)
Drug ineffective (3,112)
Fatigue (3,111)
Weight increased (2,848)
Malaise (2,766)
Weight decreased (2,703)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which INFLIXIMAB-DYYB Alternatives Have Lower Hepatic enzyme increased Risk?
INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX
INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT
INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B